-
Petros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA(R)
30 Oct 2023 15:51 GMT
… key prescription pharmaceuticals as Over-the-Counter treatment options. … people enrolled in clinical trials, 1.4%, 2 … clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin
medicines called alpha … prescription drugs to the FDA.
Visit www.fda.gov…
-
Following Encouraging FDA Feedback Petros Pharmaceuticals Initiates Self-Selection (Phase 2-Equivalent) Study for STENDRA
20 Oct 2023 09:01 GMT
… key prescription pharmaceuticals as Over-the-Counter treatment options. … people enrolled in clinical trials, 1.4%, 2 … clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin
medicines called alpha … prescription drugs to the FDA.
Visit www.fda.gov…
-
Petros Pharmaceuticals Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label
04 Oct 2023 17:59 GMT
… pharmaceuticals as Over the Counter or nonprescription treatment options … people enrolled in clinical trials, 1.4%, 2 … clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin
medicines called alpha … prescription drugs to the FDA.
Visit www.fda.gov…
-
Petros Pharmaceuticals Announces Capital Raise of $15 Million
14 Jul 2023 11:19 GMT
… Pharmaceuticals, is an oral phosphodiesterase 5 (PDE5) inhibitor for the treatment … people enrolled in clinical trials, 1.4%, … clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin
medicines called … prescription drugs to the FDA.
Visit www.fda.gov…
-
FDA Drug Safety Podcasts
16 Dec 2022 22:05 GMT
… FDA requests removal of strongest warning against using cholesterol-lowering statins … with antibiotic clarithromycin (Biaxin) in patients … medicines Chantix and Zyban to reflect clinical trial …
FDA approves brand name change for antidepressant drug Brintellix …
-
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Corporate Update
16 May 2022 21:34 GMT
… Pharmaceuticals, is an oral phosphodiesterase 5 (PDE5) inhibitor for the treatment … people enrolled in clinical trials, 1.4%, 2 … (angina) use street drugs called 'poppers,… clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin medicines called …
-
Petros Pharmaceuticals Announces Second Quarter Financial Results and Provides Corporate Update; Reports a 123% Increase in Year Over Year Quarterly STENDRA (avanafil) Net Sales
17 Aug 2021 15:55 GMT
… Drug Administration (FDA) for our erectile dysfunction (ED) medication, … Pharmaceuticals, is an oral phosphodiesterase 5 (PDE5) inhibitor for the treatment … in clinical trials, 1.4%, … (Biaxin®), telithromycin (Ketek®), or erythromycin
medicines called …
-
Clarithromycin (Biaxin): Drug Safety Communication - Potential Increased Risk of Heart Problems or Death in Patients With Heart Disease
22 Feb 2018 17:47 GMT
… FDA is advising caution before prescribing the antibiotic clarithromycin (Biaxin … , placebo-controlled CLARICOR trial provide the strongest evidence … the clarithromycin drug labels. As part of FDA’s … treatments. Do not stop taking your heart disease medicine …
-
Biaxin Heart Risks Result in FDA Warning for Individuals with Heart Disease
23 Feb 2018 18:00 GMT
… FDA issued a drug safety communication on Thursday, indicating that doctors should prescribe Biaxin … trial, which found that the risk of death among Biaxin … a five day Zithromax treatment when they compared … taking heart disease medication or an antibiotic …
-
Biaxin Linked To Increased Risk Of Bleeding Compared to Zithromax: Study
12 Jun 2020 19:16 GMT
… this week in the medical journal JAMA Internal Medicine, Canadian researchers looked … within 30 days of beginning treatment. However, Biaxin was linked to a … disease (COPD).
Tags: Antibiotics, Azithromycin, Biaxin, Bleeding, Blood Thinners, Eliquis, Hemorrhage …